The Venture Codex Logo

The Venture Codex

Swisscanto Invest

Bahnhofstrasse 9, Zürich, Zurich, 8001, Switzerland

Overview

Investing in late-stage growth companies in technology and healthtech.

Founded

2018

Deals · 12mo

0

Links

WebsiteLinkedInX (Twitter)

Stage focus

Series B
Series C

Geographic focus

Belgium
Denmark
Finland
Germany
...

Sector focus

Financial Services
Funding Platform

Investment portfolio

19rounds
NAMEDATESIZE
MedTrace Pharma
Oct 2024Led
$30 MSeries B
NIL Technology ApS
May 2024Participated
$31 MOther Equity
Memo Therapeutics
May 2024Participated
$22 MSeries C
Memo Therapeutics
Nov 2023Participated
$28 MSeries C
Nagi Bioscience
Sep 2023Led
$14 MSeries A
Distran
Jun 2023Led
$12 MSeries B
Beekeeper
Nov 2022Participated
$50 MSeries C
Memo Therapeutics
Feb 2022Led
$40 MSeries B
Fotokite
Jan 2022Participated
$15 MSeries B
Medimaps Group
Dec 2021Led
$20 MOther Equity
1plusX, a TripleLift company
Jan 2021Led
$8 MSeries B
Memo Therapeutics
Nov 2020Led
$16 MSeries B
MedTrace Pharma
Oct 2024Led
$30 MSeries B
NIL Technology ApS
May 2024Participated
$31 MOther Equity
Memo Therapeutics
May 2024Participated
$22 MSeries C
Memo Therapeutics
Nov 2023Participated
$28 MSeries C
Nagi Bioscience
Sep 2023Led
$14 MSeries A
Distran
Jun 2023Led
$12 MSeries B
Beekeeper
Nov 2022Participated
$50 MSeries C
Memo Therapeutics
Feb 2022Led
$40 MSeries B
Fotokite
Jan 2022Participated
$15 MSeries B
Medimaps Group
Dec 2021Led
$20 MOther Equity
1plusX, a TripleLift company
Jan 2021Led
$8 MSeries B
Memo Therapeutics
Nov 2020Led
$16 MSeries B
19
Items
...
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Swisscanto Invest: 19 funding rounds are recorded in the selected participation categories.All available history.
Swisscanto Invest: 19 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Series A10
Series B92
Series C+05
Other Equity11

Monthly Deal Activity

Swisscanto Invest: 19 deals are recorded across 90 months.All available history.
Swisscanto Invest: 19 deals are recorded across 90 months. All available history
MonthDeals
May '191
Jun '190
Jul '190
Aug '191
Sep '192
Oct '190
Nov '190
Dec '190
Jan '200
Feb '201
Mar '200
Apr '200
May '200
Jun '200
Jul '201
Aug '201
Sep '200
Oct '200
Nov '201
Dec '200
Jan '211
Feb '210
Mar '210
Apr '210
May '210
Jun '210
Jul '210
Aug '210
Sep '210
Oct '210
Nov '210
Dec '211
Jan '221
Feb '221
Mar '220
Apr '220
May '220
Jun '220
Jul '220
Aug '220
Sep '220
Oct '220
Nov '221
Dec '220
Jan '230
Feb '230
Mar '230
Apr '230
May '230
Jun '231
Jul '230
Aug '230
Sep '231
Oct '230
Nov '231
Dec '230
Jan '240
Feb '240
Mar '240
Apr '240
May '242
Jun '240
Jul '240
Aug '240
Sep '240
Oct '241
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

Swisscanto Invest: Health & Life Sciences is the largest displayed sector by deal count (9 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Swisscanto Invest: Health & Life Sciences is the largest displayed sector by deal count (9 deals). All available history
SectorDeals
Health & Life Sciences9
Networks, Cloud & Communication8
Enterprise Software5
Hardware & Robotics4
Manufacturing4
AR/VR3
Space & Frontier Tech3
Media & Entertainment2
Travel & Hospitality1
Government & Defense1
E-Commerce & Retail1
Data, Analytics & IT1
Real Estate & Construction1
Consumer & Lifestyle1
Marketing & Advertising1

Deal Size Distribution

Swisscanto Invest: 19 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Swisscanto Invest: 19 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M1
$10M-$25M10
$25M-$50M5
$50M-$100M2
$100M-$250M0
$250M-$500M1
$500M-$1B0
$1B+0

Deals By Geography

Swisscanto Invest: Europe has the largest recorded deal count among the displayed regions (18 deals).All available history.

Top 2 of 2 regions; European countries are grouped as Europe.

Swisscanto Invest: Europe has the largest recorded deal count among the displayed regions (18 deals). All available history
RegionDeals
Europe18
United States1
Swisscanto Invest: 20 co-investors are shown, with Verve Ventures sharing 9 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Swisscanto Invest: 20 co-investors are shown, with Verve Ventures sharing 9 recorded deals. All available history
Co-investorShared deals
Verve Ventures9
Redalpine4
Vesalius Biocapital4
Zürcher Kantonalbank4
Adjuvant Capital3
Alpana Ventures3
Fresenius Medical Care Ventures3
GF Group3
Thayer Ventures3
Atomico2
Energize Ventures2
HighSage Ventures2
Keen Venture Partners2
Pureos Bioventures2
Schroders Capital2
Swiss Post2
Swisscom2
Swisscom Ventures2
Air Liquide Venture Capital1
ATP1

Investment Strategy

Swisscanto Invest: Led accounts for 58% and participating for 42% of round participation.All available history.
Swisscanto Invest: Led accounts for 58% and participating for 42% of round participation. All available history
CategoryDeals (count)Share (%)
Led1158%
Participating842%
Swisscanto Invest: Single-lead accounts for 55% and co-led for 45% of lead dynamics.All available history.
Swisscanto Invest: Single-lead accounts for 55% and co-led for 45% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead655%
Co-led545%

Team

Robert Schier

Investment Director